Immucell Corp /De/
Nasdaq · Healthcare · In Vitro & In Vivo Diagnostic Substances · Portland, ME
ICCC chart
What traders are saying about $ICCC
Latest postsImmucell Corp /De/ news
- ZTS vs. ICCC: Which Animal Health Stock Is the Better Investment Bet?
Yahoo Finance ·
- ImmuCell Announces a 46% Increase in Product Sales in Quarter Three of 2026, Based on Preliminary, Unaudited Sales Results
Yahoo Finance ·
- The Zacks Analyst Blog Highlights Alphabet, Mastercard, AbbVie, Perma-Pipe and ImmuCell
Yahoo Finance ·
- Top Research Reports for Alphabet, Mastercard & AbbVie
Yahoo Finance ·
- ImmuCell Stock Falls 8.8% Despite Y/Y Earnings & Sales Growth in Q2
Yahoo Finance ·
- ImmuCell (ICCC) Q2 2026 Earnings Call Transcript
fool.com ·
- ImmuCell Corp (ICCC) (Q2 2026) Earnings Call Highlights: Record Net Income and Market Share ...
Yahoo Finance ·
- ImmuCell Q2 Earnings Call Highlights
marketbeat.com ·
- ImmuCell Corporation Q2 2026 Earnings Call Summary
app.moby.co ·
- ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2026
Yahoo Finance ·
- ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2026
Yahoo Finance ·
- ImmuCell Posts Strong Preliminary Q2 Sales on U.S. Demand
Yahoo Finance ·
Immucell Corp /De/ key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $27.6M | $26.5M | $17.5M | $18.6M |
| Net income | -$1.0M | -$2.2M | -$5.8M | -$2.5M |
| Diluted EPS | $-0.12 | $-0.26 | $-0.75 | $-0.32 |
| Total assets (year end) | $42.5M | $45.1M | $43.8M | $44.9M |
| Cash and equivalents (year end) | $3.8M | $3.8M | $978,741 | $5.8M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Immucell Corp /De/
- Ticker
- ICCC (Nasdaq)
- Industry
- In Vitro & In Vivo Diagnostic Substances
- Headquarters
- Portland, ME
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 811641
Frequently asked questions
What exchange is Immucell Corp /De/ listed on?
Immucell Corp /De/ trades on the Nasdaq under the ticker symbol ICCC.
What industry is Immucell Corp /De/ in?
Immucell Corp /De/ is classified by the SEC under "In Vitro & In Vivo Diagnostic Substances", part of the Healthcare sector on StockTweeting.
Where is Immucell Corp /De/ headquartered?
Immucell Corp /De/'s business address on file with the SEC is in Portland, ME.
When does Immucell Corp /De/'s fiscal year end?
Immucell Corp /De/'s fiscal year ends on December 31.
How much revenue did Immucell Corp /De/ report?
Immucell Corp /De/ reported $27.6M in revenue for calendar year 2025, according to its SEC filings.